Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 19 of 611 for:    Personality Disorders

Use of Care Services by Patients With Borderline Personality Disorder (EpiB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02829658
Recruitment Status : Completed
First Posted : July 12, 2016
Last Update Posted : May 12, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Toulouse

Brief Summary:

Borderline personality disorder (BPD) is characterized by a pervasive pattern of instability and impulsivity. Several North American prospective studies support the high level of mental health care utilization in this population. There is little data in other systems of health organization, such as France. Furthermore, little is known on the variables associated with the mental health service utilization among BPD patients.

The main objective was to compare the utilization of mental health care among BPD patients, to the general population and patients with another personality disorder (PD) and to describe the demographic and clinical factors associated with the group of patients who use the most health care.


Condition or disease Intervention/treatment
Borderline Personality Disorder Behavioral: Psychologic test Other: No intervention

Layout table for study information
Study Type : Observational
Actual Enrollment : 98 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Use of Care Services by Patients With Borderline Personality Disorder
Study Start Date : February 2009
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Psychiatric patients group
Patient groups were composed with: BPD, other PD and assessed Psychologic test
Behavioral: Psychologic test
Assessment by a psychologist including the Structured Interview for Diagnostic and Statistical Manual (DSM)-IV Personality Disorders (SIDP-IV) was given straight to those who had a score above 28. This questionnaire allowed us to distinguish one group of subjects with BPD and a group with other PD (without BPD). Clinical evaluation included Axis I (MINI), Axis II (SIDP-IV), psychopathological features (YSQ-I, Defense Style Questionnaire (DSQ-40), demographic variables and therapeutic alliance (Haq-II).

Control group
Matched controls (age, sex) composed the 3rd and 4th group (BPD control and other PD control). They were randomly chosen in the health database insurance previously used. They had no intervention.
Other: No intervention
No intervention




Primary Outcome Measures :
  1. Compare data among BPD Patients and general population [ Time Frame: during five years previously to the inclusion ]
    Utilization of mental health care


Secondary Outcome Measures :
  1. Hospitalizations [ Time Frame: During five years previously to the inclusion ]
    Compare hospitalizations between BPD patients and general population

  2. Demographics data [ Time Frame: Inclusion ]
    Compare demographic data between BPD patient and general population



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
First, four groups were composed: BPD, other PD, control groups for PD and other PD. The first two groups were recruited from a screening of inpatients including a self-administered questionnaire (Personality Disorder Questionnaire 4+). Matched controls (age, sex) composed the 3rd and 4th group (BPD control and other PD control). They were randomly chosen in the health database insurance previously used.
Criteria

Inclusion Criteria:

  • Affiliated with the health insurance
  • Inpatient Psychiatry

Exclusion Criteria:

  • Patient in forced hospitalization
  • chronic psychotic disorder, mania or hypomania state, known mental retardation.
  • Patient does not speak or read French

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02829658


Locations
Layout table for location information
France
University Hospital of Toulouse
Toulouse, France, 31000
Sponsors and Collaborators
University Hospital, Toulouse
Investigators
Layout table for investigator information
Principal Investigator: CAILHOL Lionel, MD University Hospital, Toulouse

Publications of Results:
Layout table for additonal information
Responsible Party: University Hospital, Toulouse
ClinicalTrials.gov Identifier: NCT02829658     History of Changes
Other Study ID Numbers: 08 120 03
First Posted: July 12, 2016    Key Record Dates
Last Update Posted: May 12, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Personality Disorders
Borderline Personality Disorder
Pathologic Processes
Mental Disorders